Pharmafile Logo
Pharmafocus logo
Advanced Search

heart disease

Showing 7 posts of 22 posts found.

heart-2372134_640

Heart failure mortality rates fall across England and Wales, national audit finds

August 11, 2017
Medical Communications, Research and Development cardiovascular, heart, heart disease, life sciences, pharma, pharmaceutical

Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led …

News
pancreatic_cancer_research

Heart disease drug development is falling

August 30, 2016
Manufacturing and Production, Research and Development cardiovascular disease, heart disease, research and development

The number of drugs currently in development to combat heart disease has fallen in the last 20 years, it has …

News
google logo

Google and AHA to fund $50m cardiovascular disease project

November 13, 2015
Medical Communications, Research and Development American Heart Association, cardiovascular disease, google, heart disease

The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …

News
ESC congress sign

NHS looks to ESC for next-gen heart drug data

August 28, 2015
Medical Communications, Research and Development ALN-PCScs, Repatha, alirocumab, cardiology, cardiovascular disease, cvd, evolocumab, heart disease, high cholesterol, praluent

New data is expected to be presented at the European Cardiology Society congress in London, on the high cholesterol drugs …

News
MyHeart Counts ResearchKit app

First Apple ResearchKit app launches in the UK

August 7, 2015
Medical Communications Apple, clinical trial, heart disease, researchkit, strokes

The first ResearchKit app to be made available to users outside of the US has launched in the UK. The …

News
Logos

Praluent scores positive trial results in Japan

July 9, 2015
Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent

Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …

News
BMS image

BMS enters gene therapy development deal

April 7, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025